1 / 16

Restaging the Primary Tumor

Restaging the Primary Tumor. Cameron Wright, MD Thoracic Surgery MGH 2012 Focus on Thoracic Surgery: Lung Cancer. Disclosures. None. CT Characteristics of Locally Advanced Disease. Pleural effusion and nodularity-suggestive of M1a disease- thoracentesis or VATS exploration and biopsy

armand-larson
Télécharger la présentation

Restaging the Primary Tumor

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Restaging the Primary Tumor Cameron Wright, MD Thoracic Surgery MGH 2012 Focus on Thoracic Surgery: Lung Cancer

  2. Disclosures None

  3. CT Characteristics of Locally Advanced Disease Pleural effusion and nodularity-suggestive of M1a disease-thoracentesis or VATS exploration and biopsy Chest wall invasion-signs of invasion include bone destruction, pleural thickening, loss of extrapleural fat plane, tumor extending into the chest wall and extensive contact between chest wall and tumor. Only bone destruction is 100% accurate. Mediastinal invasion-invasion of mediastinal fat, extensive contact with the mediastinal pleura (> 3 cm) or aorta (>90 degree ) suggestive of invasion. However unless there is extensive invasion CT is often unreliable.

  4. LLL Adenocarcinoma with Pleural Metastases in Fissure

  5. NCCN Restaging Guidelines • Restaging after induction therapy is difficult to interpret, but CT +/- PET should be performed to exclude disease progression or interval development of metastatic disease • Radiographic methods have a poor positive and negative predictive values in the evaluation of the mediastinum after neoadjuvant therapy • Recommendations are category 2A

  6. Comparison of Pathologic and Radiographic Response-INT-0160 • Phase II trial of induction chemoradiotherapy for superior sulcus tumors • 2 cycles of cisplatin and etoposide with concurrent 45 Gy of radiation • 83 patients underwent thoracotomy • 46% had a partial radiographic response, 54% stable disease • 34% had a pCR, 31% had microscopic residual disease, and 35% had gross residual disease • 35% with stable radiographic disease had a pCR! • 38% with a partial radiographic response had a pCR! Rusch VW et al. JTCVS 2001;121:472-83

  7. Meta Analysis-Use of PET to Predict Tumor Response Rebollo-Aguire AC et al. J SurgOncol 2010;101:486-94.

  8. Timing of Restaging PET/CT • Retrospective review of accuracy of PET/CT in staging patients after induction CT/RT • 109 patients (90% N2) • 50% ↓ Max SUV considered to be a complete response • ROC analysis suggested optimum time for restaging was 26 days • PET issues-not standardized, amount FDG given, scanning technique, glucose level, etc Cerfolio RJ, Bryant AS. Ann ThoracSurg 2007;84:1092-7.

  9. T4N0M0 SVC Involvement before and after Induction CT/RT

  10. T4 SVC Postinduction Pathology • FINAL PATHOLOGIC DIAGNOSIS: • A. RIGHT UPPER LOBE, LUNG LOBECTOMY: • Squamous cell carcinoma. See synoptic report. • B. SUPERIOR VENA CAVA, EXCISION: • Squamous cell carcinoma invading vessel wall.

  11. LUL T3N1M0 Before and After CT/RT Pre Post Post

  12. T3N1 Postinduction Pathology • FINAL PATHOLOGIC DIAGNOSIS: • A. LUNG PNEUMONECTOMY, LEFT: • Squamous cell carcinoma (4.4 cm), moderately differentiated, s/p chemoradiation • with approximately 30% of tumor mass showing necrosis. • Note: The tumor invades the hilar fat but the inked soft tissue resection • margins are free.

  13. LUL Adenocarcinoma with RLN Involvement (T4N0M0)

  14. T4 LUL after Induction CT/RT

  15. T4 LUL Pathology • FINAL PATHOLOGIC DIAGNOSIS: • A. LUNG PNEUMONECTOMY, LEFT: • HISTOLOGIC TYPE (modified WHO classification): Adenocarcinoma, acinar poorly • differentiated, two small foci of residual carcinoma (each approximately 1 cm) • amidst extensive necrosis secondary to therapy). • TUMOR SIZE (MAXIMUM DIAMETER): 10 cm.

  16. Bottom Line • Confirm absence disease progression and distant metastatic disease with appropriate scans • Review preinduction imaging for areas that lead to a concern for a complete resection • Review postinduction imaging to confirm absence of progressive disease and any response to therapy, especially in areas for concern about resectability • Exploration is always the final common denominator and often leads to findings that are better then what the CT suggests

More Related